Antithrombotische Therapie bei Vorhofflimmern – Stellungnahme zu den aktuellen Leitlinien der Europäischen Gesellschaft für Kardiologie

Vorhofflimmern - Antikoagulation

atrial fibrillation - anticoagulation

Literatur

• 1 Camm A J, Kirchhof P, Lip G Y. et al . Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).  Eur Heart J. 2010;  31 2369-2429
• 2 Dulli D A. et al . Atrial fibrillation is associated with severe acute ischemic stroke.  Neuroepidemiology. 2003;  22 118-123
• 3 Hylek E M, Evans-Molina C, Shea C. et al . Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.  Circulation. 2007;  115 2689-2696
• 4 Luengo-Fernandez R. et al . Population-Based Study of Determinants of Initial Secondary Care Costs of Acute Stroke in the United Kingdom.  Stroke. 2006;  37 2579-2587
• 5 Mant J, Hobbs F D, Fletcher K, Roalfe A, Fitzmaurice D, Lip G Y, Murray E. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.  Lancet. 2007;  370 493-503
• 6 Pisters R, Lane D A, Nieuwlaat R. et al . A novel userfriendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey.  Chest. 2010;  138 1093-100
• 7 Rash A, Downes T, Portner R. et al . A randomised, controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).  Age Ageing. 2007;  36 151-156
• 8 Slot K B. et al., for the Oxfordshire Community Stroke Project, the International Stroke Trial (UK); Lothian Stroke Register . Impact of functional status at six months on long-term survival in patients with ischemic stroke: prospective cohort studies.  Br Med J. 2008;  7640 376-379